Breaking News Instant updates and real-time market news.

KEYS

Keysight Technologies

$57.15

0.68 (1.20%)

, CA

Bought by AVGO

$44.26

0.08 (0.18%)

18:13
10/30/18
10/30
18:13
10/30/18
18:13

S&P announces changes to S&P 400, 500, 600 indices

S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent Keysight Technologies (KEYS) will replace CA (CA) in the S&P 500, S&P SmallCap 600 constituent Ligand Pharmaceuticals (LGND) will replace Keysight Technologies in the S&P MidCap 400, and Marcus & Millichap (MMI) will replace Ligand Pharmaceuticals in the S&P SmallCap 600 prior to the open of trading on Tuesday, November 6. S&P 500 constituent Broadcom (AVGO) is acquiring CA in a deal expected to close on or about that date pending final conditions. Arcosa (ACA) will replace KapStone Paper and Packaging (KS) in the S&P SmallCap 600 effective prior to the open of trading on Monday, November 5. S&P MidCap 400 constituent Trinity Industries (TRN) is spinning off Arcosa to shareholders in a deal expected to be completed on November 1. Post spin-off, Trinity Industries will remain in the S&P MidCap 400. S&P 500 constituent WestRock (WRK) is acquiring Kapstone Paper and Packaging in a deal expected to close on or about November 2 pending final conditions.

KEYS

Keysight Technologies

$57.15

0.68 (1.20%)

CA

Bought by AVGO

$44.26

0.08 (0.18%)

LGND

Ligand

$173.09

6.32 (3.79%)

MMI

Marcus & Millichap

$32.29

0.69 (2.18%)

AVGO

Broadcom

$221.14

9.11 (4.30%)

ACA

Arcosa

$0.00

(0.00%)

KS

KapStone

$34.99

3.35 (10.59%)

TRN

Trinity Industries

$28.26

0.77 (2.80%)

WRK

WestRock

$42.84

1.9 (4.64%)

  • 05

    Nov

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 20

    Nov

KEYS Keysight Technologies
$57.15

0.68 (1.20%)

10/18/18
GSCO
10/18/18
UPGRADE
Target $305
GSCO
Conviction Buy
Semi re-stack puts Nvidia on Goldman Conviction List with 25% upside
Goldman Sachs analyst Toshiya Hari this morning added Buy-rated Nvidia (NVDA) to his firm's Conviction List while lowering his price target for the shares to $305 from $324. The stock in morning trading is up 85c to $243.91. Following a "significant correction" in the stock's valuation, the analyst expects Nvidia's "idiosyncratic growth drivers," like its product cycle in Gaming and potential share gains in Data Center, to drive share outperformance. While lowering his January quarter earnings per share estimate to $1.90 from $2.28 to reflect potential volume and average selling price weakness in the Gaming business, Hari recommends investors to buy the stock at current levels with his long-term thesis intact. He sees potential upside of 25% for Nvidia shares. Positive earnings revisions post the Q3 earnings report should serve as a positive catalyst for the stock, contends the analyst. Putting Nvidia on his firm's Conviction List was part of Hari's rating re-stack in the Semiconductors sector. Also this morning, the analyst downgraded both Analog Devices (ADI) and Maxim Integrated Products (MXIM) to Sell from Neutral, downgraded Teradyne (TER) to Neutral from Buy, upgraded both Keysight Technologies (KEYS) and NXP Semiconductors (NXPI) to Buy from Neutral, and upgraded Texas Instruments (TXN) to Neutral from Sell. Hari also maintained a Conviction List Buy rating on Xilinx (XLNX) and a Sell rating on Intel (INTC).
10/18/18
GSCO
10/18/18
UPGRADE
Target $76
GSCO
Buy
Goldman says Keysight exposed to 'right' markets, upgrades to Buy from Neutral
Goldman Sachs analyst Toshiya Hari upgraded Keysight Technologies to Buy from Neutral and raised his price target for the shares to $76 from $66. The company's sizable exposure to two end-markets, Communications and Defense, makes it defensively positioned within the Semiconductor space, Hari tells investors in a research note on the sector where he made several changes to his ratings. The analyst, who sees improving growth in the Wireless Communications and Defense end markets, believes Keysight is exposed to the "right" markets. His new price target represents 20% share upside.
10/22/18
STFL
10/22/18
INITIATION
STFL
Buy
Keysight Technologies resumed with a Buy at Stifel
Stifel analyst John Marchetti resumed coverage of Keysight Technologies with a Buy rating and $73 price target, citing "company specific tailwinds around 5G, automotive and software combined with a generally constructive view of the core T&M market to drive revenue growth above the company's core target of 4%-5%," along with the company's flexible cost structure and strong operational controls.
10/18/18
GSCO
10/18/18
UPGRADE
GSCO
Buy
Keysight Technologies upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Toshiya Hari upgraded Keysight Technologies to Buy while re-stacking his ratings in the Semiconductors space.
CA Bought by AVGO
$44.26

0.08 (0.18%)

09/17/18
PIPR
09/17/18
NO CHANGE
Target $90
PIPR
Overweight
CyberArk price target raised to $90 from $72 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for CyberArk (CYBR) to $90 and keeps an Overweight rating on the shares. Within the last two months, Beyond Trust, CA (Technologies (CA) and Centrify were all acquired, some of which are already creating near-term disruption, Nowinski tells investors in a research note. The analyst believes CyberArk is well positioned to capitalize on this disruption. He notes the takeovers have already led to some layoffs and will likely require extensive work to merge the code bases of the products with the parent company's broader portfolio.
09/07/18
BERN
09/07/18
NO CHANGE
Target $310
BERN
Outperform
Broadcom offers attractive risk-reward at current levels, says Bernstein
Bernstein analyst Stacy Rasgon reiterated an Outperform rating and $310 price target on Broadcom (AVGO) following the company's "strong" Q3 report and a similarly strong outlook for Q4. In a research note to investors, Rasgon says that while the recent volatility following the CA (CA) deal announcement was "painful," they may be on the mend as "there was a lot to like" on the company's conference call, including explaining the strategic rationale behind the deal. The stock remains "incredibly cheap," she adds, offering attractive risk-reward.
09/07/18
CHLM
09/07/18
NO CHANGE
Target $300
CHLM
Buy
Broadcom price target cut to $300 from $330 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss reiterated a Buy rating on Broadcom (AVGO) following the company's quarterly results, telling investors in a research note that he likes the rationale behind the CA (CA) deal as the lines blur between hardware and software. While Stoss likes the risk-reward with Broadcom trading at ~10x his FY19 numbers, the analyst lowered his price target to $300 from $330 as he waits for the company to further execute on the CA deal.
09/25/18
PIPR
09/25/18
NO CHANGE
Target $293
PIPR
Overweight
Broadcom screens cheap across several valuation metrics, says Piper Jaffray
Piper Jaffray analyst Harsh Kumar says he looked at Broadcom (AVGO) across several valuation metrics and the shares stood out as cheap in all earnings, free cash flow, and dividend valuation methods. The analyst believes the stand-alone company can raise its fiscal 2019 dividend to over $9.60. When including the impact of CA Technologies (CA), Kumar believes the dividend could be over $12.50 in fiscal 2020. Further, he believes Broadcom's fundamentals are healthy. The analyst reiterates an Overweight rating on the shares with a $293 price target.
LGND Ligand
$173.09

6.32 (3.79%)

10/02/18
HCWC
10/02/18
NO CHANGE
Target $280
HCWC
Buy
Ligand price target raised to $280 from $270 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Ligand Pharmaceuticals (LGND) to $280 after Viking Therapeutics (VKTX) and investigators presented updated VK5211 data in an oral plenary presentation at the American Society of Bone and Mineral Research meeting. VK5211 produces significant muscle growth in hip fracture patients and treated patients experienced overall weight gain, with loss of body fat, Pantginis tells investors in a research note. The analyst believes the chances for an outright acquisition of Viking has increased with VK2809 and VK5211 having the potential to address very large markets. He keeps a Buy rating on Ligand.
10/18/18
HCWC
10/18/18
NO CHANGE
Target $280
HCWC
Buy
Ligand current valuation brings attractive entry point, says H.C. Wainwright
Ligand Pharmaceuticals (LGND) partner Novartis (NVS) announced this morning Q3 Promacta revenue of $295M, H.C. Wainwright analyst Joseph Pantginis tells investors in a research note. The sales missed his estimate of $318M and came close to the consensus of $295.8M. Importantly, in the first nine months of 2018, Promacta total sales were $844M, representing 37% growth for the first nine-month period in 2017, the analyst points out. He continues to be impressed with the Promacta franchise, which he notes represents a cornerstone of Ligand's royalty revenue for the long term. Pantginis believes the recent pullback in shares of Ligand presents an attractive entry point and "compelling accumulation opportunity." He reiterates a Buy rating on the name with a $280 price target.
10/29/18
ROTH
10/29/18
UPGRADE
ROTH
Buy
Ligand upgraded to Buy from Neutral at Roth Capital
10/29/18
10/29/18
UPGRADE
Target $195

Buy
Ligand upgraded to Buy on 'strong' fundamentals at Roth Capital
As previously reported, Roth Capital analyst Scott Henry upgraded Ligand to Buy from Neutral following a 40% decline in the share price. The analyst argues that fundamentals remain strong and lowered 2019 outlook should be more conservative. Further, Henry targets upside to shares even with more conservative numbers. The analyst lowered his price target on the shares to $195 from $250.
MMI Marcus & Millichap
$32.29

0.69 (2.18%)

02/02/18
WBLR
02/02/18
INITIATION
WBLR
Market Perform
Marcus & Millichap assumed with a Market Perform at William Blair
William Blair analyst Stephen Sheldon assumed coverage of Marcus & Millichap with a Market Perform rating.
03/21/18
WELS
03/21/18
NO CHANGE
Target $37
WELS
Market Perform
Marcus & Millichap price target raised to $37 from $31 at Wells Fargo
Wells Fargo analyst Blaine Heck raised his price target for Marcus & Millichap to $37 from $31 to reflect Q4 earnings, recent asset recycling announcements, and management commentary at recent industry conferences. The analyst reiterates a Market Perform rating on the shares.
07/02/18
SBSH
07/02/18
NO CHANGE
Target $46
SBSH
Buy
Marcus & Millichap price target raised to $46 from $39 at Citi
Citi analyst Peter Christiansen raised his price target for Marcus & Millichap to $46 saying the stock's inclusion in Vanguard's Real Estate Index ETF is supportive of a higher multiple. The analyst believes Marcus & Millichap shares will benefit from this implementation for several months. He keeps a Buy rating on the name.
08/22/18
JMPS
08/22/18
DOWNGRADE
JMPS
Market Perform
Marcus & Millichap downgraded to Market Perform at JMP Securities
AVGO Broadcom
$221.14

9.11 (4.30%)

10/04/18
KEYB
10/04/18
NO CHANGE
KEYB
Carrier survey indicates healthy start for Apple iPhone XS, says KeyBanc
KeyBanc analyst John Vinh says his initial round of carrier survey for the current Apple (AAPL) iPhone XS cycle indicates "solid" sell-through for the iPhone XS/Max as inventories are lean post launch. Demand for the iPhone XS Max has been the strongest, with the majority of stores being sold out, while inventories for the iPhone XS are very healthy, he adds. The analyst also notes that demand for the new models appear to be better compared to the iPhone 8/X launch last year, driven mainly by the adoption of a larger screen at iPhone XS Max. Additionally, Vinh is encouraged with the robust results despite limited promotional activity. His favorite Apple supply chain names are Broadcom (AVGO), Qorvo (QRVO), Skyworks (SWKS), and Synaptics (SYNA).
10/19/18
PIPR
10/19/18
NO CHANGE
PIPR
Piper Jaffray lists 'stocks to own' following tech sector sell-off
Piper Jaffray's tech analysts highlighted their "stocks to own" following the recent sell-off in the technology sector. The firm's top picks across each coverage universe include Amazon.com (AMZN), Broadcom (AVGO), Salesforce (CRM), Finisar (FNSR), Microchip (MCHP), Mellanox (MLNX), ServiceNow (NOW), Nutanix (NTNX), Proofpoint (PFPT), Impinj (PI), Take-Two (TTWO) and Twilio (TWLO).
10/08/18
JPMS
10/08/18
NO CHANGE
JPMS
Broadcom custom chip business with Google could hit $1B, says JPMorgan
JPMorgan analyst Harlan Sur says that while there's been a lot of focus around Broadcom's (AVGO) "strong" mobile position at Apple (AAPL), he wants to remind investors of a diversification driver for the company and the "large opportunities" for its datacenter segment, which he notes is growing at a double-digits year-over-year growth rate. The analyst also believes that Google (GOOG, GOOGL) has also engaged with Broadcom on a number of other custom application-specific integrated circuit chip programs. Broadcom's custom ASIC chip business with Google could go from $50M-$75M in 2017 to $800M- $1B over the next 12-18 months and be as big or bigger than Broadcom's custom ASIC chip business at Apple, Sur tells investors in a research note. The analyst thinks the engagement with Google should help Broadcom's datacenter sub-segment sustain double-digit year-over-year growth over the coming years.
10/26/18
BNCH
10/26/18
NO CHANGE
Target $100
BNCH
Buy
Mellanox a 'prized' target for 'host of buyers,' says Benchmark
After CNBC reported that Mellanox (MLNX) has hired an advisor to explore strategic alternatives, including a possible sale, Benchmark analyst Gary Mobley said it is difficult to verify the story but he believes the company would "represent a prized M&A target for a host of buyers," including potentially Nvidia (NVDA), Intel (INTC), Broadcom (AVGO), Marvell (MRVL) and "even" IBM (IBM). The analyst, who added that Mellanox's "initial apathy" toward prior M&A talks with Marvell was part of the reason Starboard got involved, keeps a Buy rating on Mellanox shares with a $100 price target.
ACA Arcosa
$0.00

(0.00%)

KS KapStone
$34.99

3.35 (10.59%)

02/08/18
DADA
02/08/18
DOWNGRADE
DADA
Neutral
KapStone downgraded to Neutral from Buy at DA Davidson
02/09/18
DADA
02/09/18
DOWNGRADE
Target $35
DADA
Neutral
KapStone downgraded to Neutral at DA Davidson on WestRock acquistion
As reported earlier, DA Davidson analyst Steven Chercover downgraded KapStone (KS) to Neutral from Buy and raised his price target to $35 from $28 after the recent offer by WestRock (WRK) to acquire the company at his target price point. The analyst believes it values the company fairly and does not expect a higher offer.
05/29/18
SPHN
05/29/18
NO CHANGE
SPHN
Nine Dragons deal increases uncertainty in containerboard market, says Stephens
Stephens analyst Mark Connelly noted that private Canadian printing paper and pulp producer Catalyst Paper agreed to sell its Maine and Wisconsin softwood paper mills to China's Nine Dragons, which he sees increasing uncertainty in the containerboard market and likely to further reduce investor interest in the space. Among companies in the space, Connelly currently recommends only Packaging Corp. (PKG). Others in the space include International Paper (IP), KapStone (KS), Domtar (UFS) and WestRock (WRK).
09/21/18
WELS
09/21/18
INITIATION
Target $63
WELS
Market Perform
WestRock initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Gabe Hajde resumed coverage of WestRock (WRK) with a Market Perform rating and $63 price target, stating that uncertainty on the pending KapStone (KS) acquisition, an upcoming heavy capital spending cycle and broader investor concern about industry capacity leave the stock's risk/reward balanced at this point. Over the longer-term, Hajde believes WestRock maintains an inherent and sustainable competitive advantage and he is bullish on its ability to capture industry-proportionate growth in the North American corrugated market.
TRN Trinity Industries
$28.26

0.77 (2.80%)

10/30/18
SPIN
10/30/18
UPGRADE
SPIN
Buy
Trinity Industries upgraded to Buy from Hold at Spin-Off Research
10/08/18
SPIN
10/08/18
DOWNGRADE
SPIN
Hold
Trinity Industries downgraded to Hold from Buy at Spin-Off Research
10/05/18
MZHO
10/05/18
NO CHANGE
Target $48
MZHO
Buy
Trinity Industries solidified case for Arcosa spin-off, says Mizuho
Mizuho analyst Kristine Kubacki believes Trinity Industries management solidified the case for the spin-off of Arcosa at the company's analyst day. The analyst liked what she heard about the strategy for the rail manufacturing and leasing businesses and keeps a Buy rating on the shares with a $48 price target. She sees a "revaluation of a pure-play rail equipment leasing business" and higher manufacturing earnings as potential positive catalysts for 2019.
09/20/18
09/20/18
UPGRADE

Hold
Vertical Group upgrades Trinity Industries to Hold on near-term demand strength
As previously reported, Vertical Group analyst Gordon Johnson upgraded Trinity Industries to Hold from Sell given the near-term upside he sees from "raging" demand for petroleum cars and his checks suggesting the market is currently short double-lined tank railcars. However, he also believes the current pressure on railcar leasing rates will prove structural and that U.S. pipeline build-outs will permanently kill tank car demand, leaving Johnson more cautious on the long-term outlook for Trinity.
WRK WestRock
$42.84

1.9 (4.64%)

10/10/18
GSCO
10/10/18
DOWNGRADE
Target $53
GSCO
Neutral
International Paper downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Brian Maguire downgraded International Paper (IP) to Neutral and lowered his price target for the shares to $53 from $63. The stock closed yesterday down $2.69 to $44.64. Following 12 new U.S. containerboard capacity announcements since his upgrade of the shares on July 12, 2017, the analyst now forecasts 11% growth in North American capacity from 2019-2022 against an estimate of 2% per year demand growth. U.S. containerboard supply growth will outpace demand growth during the 2020-2022 period, which increases the risk of pricing/earnings declines in that time period, Maguire tells investors in a research note. The analyst admits that he underestimated the speed and severity of the supply response in the industry to the acceleration in demand. Maguire also lowered his price target for Buy-rated WestRock (WRK) to $64 from $73 and removed the shares from his firm's Americas Conviction List. He also dropped his price target for Neutral-rated Packaging Corp. (PKG) to $108 from $119.
10/10/18
GSCO
10/10/18
DOWNGRADE
Target $64
GSCO
Buy
WestRock downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Brian Maguire removed WestRock from his firm's Americas Conviction List while keeping a Buy rating on the shares. The analyst also lowered his price target for the stock to $64 from $73. Following 12 new U.S. containerboard capacity announcements since July 2017, the analyst now forecasts 11% growth in North American capacity from 2019-2022 against an estimate of 2% per year demand growth. U.S. containerboard supply growth will outpace demand growth during the 2020-2022 period, which increases the risk of pricing/earnings declines in that time period, Maguire tells investors in a research note. The analyst admits that he underestimated the speed and severity of the supply response in the industry to the acceleration in demand.
10/10/18
10/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Vipshop (VIPS) downgraded to Neutral from Overweight at JPMorgan with analyst Alex Yao saying as the "tough competitive environment and harder-than-expected synergy generation," Vipshop is likely to adjust its strategy to re-focus on core off-season apparel distribution and prioritize profitability over sales growth. 2. International Paper (IP) downgraded to Neutral from Buy at Goldman Sachs while WestRock (WRK) was downgraded to Buy from Conviction Buy. 3. Clorox (CLX), Church & Dwight (CHD), and Kimberly-Clark (KMB) were downgraded to Sell from Hold at Deutsche Bank. 4. Sherwin-Williams (SHW) downgraded to Neutral from Buy at Citi with analyst P.J. Juvekar saying "tough" market comments from companies like H.B. Fuller (FUL), PPG (PPG) and RPM (RPL) suggest that coatings companies are likely to be challenged by rising raw materials costs and slowing growth in key end markets, including China. 5. KKR (KKR) downgraded to Neutral from Buy at BofA/Merrill with analyst Michael Carrier citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/23/18
BOFA
10/23/18
INITIATION
Target $52
BOFA
Buy
WestRock initiated with a Buy at BofA/Merrill
Seaport Global analyst Mark Weintraub initiated WestRock with a Buy and $52 price target telling investors shares are "too cheap." Weintraub said WestRock is gaining ground on competitors in Corrugated, and expects it to turn the corner in Consumer Packaging in 2019.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$43.17

0.82 (1.94%)

, AEO

American Eagle

$15.40

0.63 (4.27%)

19:34
08/18/19
08/18
19:34
08/18/19
19:34
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

CMCSA

Comcast

$43.17

0.82 (1.94%)

AEO

American Eagle

$15.40

0.63 (4.27%)

MO

Altria Group

$46.48

1 (2.20%)

CMCSK

Comcast

$0.00

(0.00%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 04

    Sep

  • 25

    Sep

  • 25

    Sep

  • 27

    Oct

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

19:27
08/18/19
08/18
19:27
08/18/19
19:27
Periodicals
Trump does not want to do business with Huawei, Reuters reports »

President Donald Trump…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XYF

X Financial

$2.61

0.04 (1.56%)

19:25
08/18/19
08/18
19:25
08/18/19
19:25
Earnings
X Financial reports Q2 EPS 31c, consensus 22c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

VJET

Voxeljet

$1.64

-0.05 (-2.96%)

18:44
08/18/19
08/18
18:44
08/18/19
18:44
Recommendations
Voxeljet analyst commentary at Piper Jaffray »

Voxeljet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

$0.00

(0.00%)

, AAPL

Apple

$206.44

4.71 (2.33%)

18:40
08/18/19
08/18
18:40
08/18/19
18:40
Periodicals
Apple CEO warns Trump about China tariffs, Reuters reports »

President Donald Trump…

SSNLF

Samsung

$0.00

(0.00%)

AAPL

Apple

$206.44

4.71 (2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

T

AT&T

$34.98

0.64 (1.86%)

, CMCSA

Comcast

$43.17

0.82 (1.94%)

18:05
08/18/19
08/18
18:05
08/18/19
18:05
On The Fly
Box Office Battle: 'Good Boys' wins weekend with $21M debut »

"Box Office Battle" is…

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$55.72

0.64 (1.16%)

LGF.A

Lionsgate

$11.06

0.02 (0.18%)

LGF.B

Lionsgate

$10.52

0.01 (0.10%)

DIS

Disney

$135.19

1.79 (1.34%)

VIAB

Viacom

$26.02

0.09 (0.35%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Oct

  • 27

    Oct

SFTBF

SoftBank

$0.00

(0.00%)

, SFTBY

SoftBank

$0.00

(0.00%)

17:59
08/18/19
08/18
17:59
08/18/19
17:59
Periodicals
Softbank plans to lend up to $20B to employees to invest in new fund, WSJ says »

Softbank is planning to…

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

16:50
08/18/19
08/18
16:50
08/18/19
16:50
Periodicals
Trump administration to give Huawei more time to work with U.S. clients,WSJ says »

The Trump administration…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JSAIY

J Sainsbury

$0.00

(0.00%)

16:46
08/18/19
08/18
16:46
08/18/19
16:46
Periodicals
J Sainsbury's not talking to internal candidates for CEO succession,Reuters says »

J Sainsbury's is not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$219.92

4.27 (1.98%)

16:39
08/18/19
08/18
16:39
08/18/19
16:39
Hot Stocks
Tesla relaunching solar-panel business with no-contract rentals »

Tesla is now offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 23

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

16:14
08/18/19
08/18
16:14
08/18/19
16:14
Periodicals
White House says no recession in sight, Reuters reports »

White House officials…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$89.46

0.91 (1.03%)

16:11
08/18/19
08/18
16:11
08/18/19
16:11
Periodicals
Novartis executive sold shares before data manipulation made public,Reuters says »

An unnamed Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

MO

Altria Group

$46.48

1 (2.20%)

16:08
08/18/19
08/18
16:08
08/18/19
16:08
Periodicals
CDC investigating lung illness linked to e-cigarette use, Reuters reports »

The Centers for Disease…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFB

CrossFirst Bancshares

$14.61

(0.00%)

, JFU

9F Inc

$10.09

0.52 (5.43%)

08:48
08/18/19
08/18
08:48
08/18/19
08:48
On The Fly
Opening Day: CrossFirst rises after setting IPO share price lower than expected »

Shares of CrossFirst…

CFB

CrossFirst Bancshares

$14.61

(0.00%)

JFU

9F Inc

$10.09

0.52 (5.43%)

NET

Cloudflare

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

SDC

SmileDirectClub

$0.00

(0.00%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

MSFT

Microsoft

$136.13

2.39 (1.79%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

CBS

CBS

$43.83

0.5 (1.15%)

, VIA

Viacom

$27.27

-0.4 (-1.45%)

08:03
08/17/19
08/17
08:03
08/17/19
08:03
Periodicals
Viacom-CBS merger got panned by investors, Barron's says »

CBS (CBS) and Viacom…

CBS

CBS

$43.83

0.5 (1.15%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

VIAB

Viacom

$26.02

0.09 (0.35%)

AAPL

Apple

$206.44

4.71 (2.33%)

DIS

Disney

$135.19

1.79 (1.34%)

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$302.74

6.81 (2.30%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

  • 27

    Oct

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

07:57
08/17/19
08/17
07:57
08/17/19
07:57
Periodicals
Myriad Genetics stock might have an FDA issue, Barron's says »

Myriad Genetics plunged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$46.96

0.73 (1.58%)

, NTAP

NetApp

$46.75

0.33 (0.71%)

07:50
08/17/19
08/17
07:50
08/17/19
07:50
Periodicals
Trade war hitting tech stocks, Barron's says »

Cisco (CSCO) plunged 9% a…

CSCO

Cisco

$46.96

0.73 (1.58%)

NTAP

NetApp

$46.75

0.33 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 10

    Oct

  • 13

    Nov

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

, RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

07:47
08/17/19
08/17
07:47
08/17/19
07:47
Periodicals
Investors should not abandon oil, gas stocks, Barron's says »

Energy stocks have rarely…

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

CVX

Chevron

$115.79

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

TGT

Target

$84.20

1.67 (2.02%)

, WMT

Walmart

$112.99

0.32 (0.28%)

07:40
08/17/19
08/17
07:40
08/17/19
07:40
Periodicals
Grocery Outlet thriving as rivals struggle, Barron's says »

While Dow was down 800…

TGT

Target

$84.20

1.67 (2.02%)

WMT

Walmart

$112.99

0.32 (0.28%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AEO

American Eagle

$15.40

0.63 (4.27%)

07:33
08/17/19
08/17
07:33
08/17/19
07:33
Periodicals
American Eagle to soar despite trade war, Barron's says »

American Eagle's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

, MTCH

Match Group

$84.53

2.08 (2.52%)

07:27
08/17/19
08/17
07:27
08/17/19
07:27
Periodicals
Dating business might be IAC's best asset, greatest challenge, Barron's says »

IAC (IAC) has rallied 34%…

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

MTCH

Match Group

$84.53

2.08 (2.52%)

IAC

IAC

$249.17

4.21 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 10

    Oct

AAPL

Apple

$206.44

4.71 (2.33%)

, HAS

Hasbro

$114.29

1.13 (1.00%)

07:13
08/17/19
08/17
07:13
08/17/19
07:13
On The Fly
Week in review How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$206.44

4.71 (2.33%)

HAS

Hasbro

$114.29

1.13 (1.00%)

MAT

Mattel

$10.74

(0.00%)

AGR

Avangrid

$49.29

0.37 (0.76%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 09

    Sep

  • 02

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 27

    Oct

NCLH

Norwegian Cruise Line

$50.48

1.38 (2.81%)

18:04
08/16/19
08/16
18:04
08/16/19
18:04
Hot Stocks
Norwegian Cruise Line CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$27.12

0.14 (0.52%)

18:01
08/16/19
08/16
18:01
08/16/19
18:01
Hot Stocks
Regional Management CFO buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RTN

Raytheon

$178.10

-0.42 (-0.24%)

17:59
08/16/19
08/16
17:59
08/16/19
17:59
Hot Stocks
Raytheon awarded $199.59M Navy contract for MK 15 CIWS »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.